Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Sanofi reception

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Dieter Weinand to be based in key US market

- PMLiVE

Shire’s bleeding disorder drug approved in Europe

Veyvondi for patients with rare disease von Willebrand disease

Bristol Myers Squibb logo

BMS psoriasis drug hits the mark in phase II

Tyrosine kinase 2 (Tyk2) inhibitors could play major role

- PMLiVE

imc, ROAD, Executive Insight and Life Healthcare adds to teams

The latest med comms movers

- PMLiVE

Seduce anyone in four simple steps

You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Page & Page Health

- PMLiVE

Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

The agency's role in unlocking the future of medicine, today.

Lighthouse Medical Communications US makes the list of finalists for the 2018 PM360 Trailblalzer Awards

Lighthouse Medical Communications US, part of the award-winning Lucid Group of companies, is delighted to announce that their ACT on Anemia campaign, developed in collaboration with the American Kidney Fund,...

Lucid Group Communications Limited

- PMLiVE

FCB Health Network launches Area 23 On Hudson

New agency will be based in New York, US

- PMLiVE

Gilead optimistic about Yescarta deal in UK

Says NICE and NHS England understand groundbreaking nature of CAR-T

- PMLiVE

Gilead and Galapagos JAK contender scores in RA trial

Trial adds to rivalry with AbbVie

- PMLiVE

FDA awards another non-opioid pain drug breakthrough status

Second drug fast-tracked amid addiction epidemic

Patient Engagement for the Life Sciences

Patient Engagement for the Life Sciences, written by Guy Yeoman and Mitchell Silva with editorial and design support from Cuttsy+Cuttsy, explains the ‘why’ and the ‘how’ of patient engagement. It...

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links